Ensysce Biosciences Inc Ordinary Shares ENSC 深 沪
等待开盘 09-20 09:30:00 美东时间
0.3303
0.000
0.00%
华盛通- 最 高0.3402
- 今 开0.3402
- 成交量 27.92万股
- 最 低 0.3215
- 昨 收 0.3303
- 总市值 242.08万
- 52周最高 2.06
- 市盈率 静 --
- 换手率 3.81%
- 52周最低 0.313
- 委 比 -88.07%
- 总股本 732.92万
- 历史最高 4108.80
- 量 比 1.38
- 振 幅 5.66%
- 历史最低 0.313
- 每 手 1
- 风险率 0.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ensysce Biosciences announces $5M concurrent offering, shares fall
Ensysce Biosciences (NASDAQ:ENSC) said on Thursday it has entered into an agreement to issue 3.5M of its common shares at a price of $0.47 per share in a registered direct offering. The company also e...
08-30 03:36
Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?
Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registered direct offering and concurrent private placement.
08-29 23:10
Ensysce wins $14M federal grant for lead pain therapy
Nano-cap biotech Ensysce Biosciences (NASDAQ:ENSC) surged ~62% in the premarket trading on Tuesday after receiving a $14M grant from the U.S. government to support investigations into its lead pain th...
08-27 20:43
Watching Ensysce Biosciences; Zacks Small-Cap Research Gives Stock $17.25 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_08152024_ENSC_Sorensen.pdf
08-16 00:11
Ensysce Biosciences regains Nasdaq compliance
Ensysce Biosciences (NASDAQ:ENSC) said it got a notice from Nasdaq, stating that the company has regained compliance. As a result, Ensysce common stock will continue trading on Nasdaq's Capital Market...
05-28 20:48
Ensysce Biosciences GAAP EPS of -$0.55
Ensysce Biosciences press release (NASDAQ:ENSC): Q1 GAAP EPS of -$0.55. Cash and cash equivalents were $3.4 million as of March 31, 2024, compared to $1.1 million as of December 31, 2023. More on Ensy...
05-13 21:16
Market-Moving News for January 31st
ENSC: 92% | Ensysce Biosciences Reports Completion Of A Constructive End Of Phase 2 Meeting With FDA Regarding Its Lead 'Next Generation' Analgesic, PF614; Phase 3 Program Expected To Begin Enrollment
01-31 21:36
Crude Oil Down 1%; Lockheed Martin Earnings Top Views
U.S. stocks traded mixed toward the end trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.26% to 37,903.57 while the NASDAQ rose 0.25% to 15,399.02. The S&P 500 also rose, gaining, 0.18% to 4,859.01.
01-24 04:01
Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.43% to 37,837.65 while the NASDAQ fell 0.01% to 15,358.79. The S&P 500 also fell, dropping, 0.03% to 4,849.05.
01-24 01:17
Market-Moving News for January 23rd
RUM: 19% | Rumble Announces Public Launch of Rumble Studio ENSC: 59% | Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted For PF614-MPAR BABA: 7% | Bloomberg
01-23 21:36
